Cape Verde vs Malaysia: Average cost of tuberculosis treatment by type
Cape Verde
30 constant 2022 US$
in 2024
Malaysia
35 constant 2022 US$
in 2024
Cape Verde rank
17th
Malaysia rank
15th
Average cost of tuberculosis treatment by type over time
- Cape Verde
- Malaysia
How they compare
Malaysia currently reports 35 constant 2022 US$ against 30 constant 2022 US$ in Cape Verde, a difference of 5 constant 2022 US$.
That makes Malaysia's figure about 1.2 times Cape Verde's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Cape Verde ahead.
Cape Verde ranks 17th and Malaysia ranks 15th of 62 countries.
Across the 2 decades both report, Cape Verde averaged higher in 1 and Malaysia in 1.
Head to head by decade
| Decade | Cape Verde | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30 constant 2022 US$ | 2 constant 2022 US$ | 28 constant 2022 US$ | Cape Verde |
| 2020s | 30 constant 2022 US$ | 33.4 constant 2022 US$ | 3.4 constant 2022 US$ | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Cape Verde or Malaysia?
- Malaysia, at 35 constant 2022 US$ against 30 constant 2022 US$ in Cape Verde as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Cape Verde and Malaysia?
- 5 constant 2022 US$, with Malaysia ahead.
- How many years of comparable data are there for Cape Verde and Malaysia?
- 6 years are reported by both, from 2019 to 2024.
- How do Cape Verde and Malaysia rank globally for average cost of tuberculosis treatment by type?
- Cape Verde ranks 17th and Malaysia ranks 15th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.